• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[68Ga]-DOTATATE PET/CT与PET/MRI在嗅神经母细胞瘤诊断与治疗中的应用:病例展示

[68Ga]-DOTATATE PET/CT and PET/MRI in the diagnosis and management of esthesioneuroblastoma: illustrative cases.

作者信息

Roytman Michelle, Tassler Andrew B, Kacker Ashutosh, Schwartz Theodore H, Dobri Georgiana A, Strauss Sara B, Capalbo Alyssa M, Magge Rajiv S, Barbaro Marissa, Lin Eaton, Osborne Joseph R

机构信息

Departments of Radiology.

Otolaryngology, Head and Neck Surgery.

出版信息

J Neurosurg Case Lessons. 2021 Jan 11;1(2):CASE2058. doi: 10.3171/CASE2058.

DOI:10.3171/CASE2058
PMID:35854930
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9241319/
Abstract

BACKGROUND

Esthesioneuroblastoma (ENB), also known as olfactory neuroblastoma, is a rare sinonasal neuroectodermal malignancy with a slow onset of symptoms, favorable 5-year survival, and a propensity for delayed locoregional recurrence. Current treatment options include resection, adjuvant radiotherapy, and/or chemotherapy; however, because of its rarity and location, determining the optimal treatment for ENB has been challenging.

OBSERVATIONS

ENBs strongly express somatostatin receptors (SSTRs), particularly SSTR2, providing a molecular target for imaging and therapy.

LESSONS

The authors present a case series of ENBs imaged with [68Ga]-DOTATATE PET/MRI and PET/CT and discuss the emerging role of [68Ga]-DOTATATE PET for ENB diagnosis, staging, and treatment response monitoring.

摘要

背景

嗅神经母细胞瘤(ENB),也称为嗅觉神经母细胞瘤,是一种罕见的鼻窦神经外胚层恶性肿瘤,症状出现缓慢,5年生存率良好,且有局部区域延迟复发的倾向。目前的治疗选择包括手术切除、辅助放疗和/或化疗;然而,由于其罕见性和位置,确定ENB的最佳治疗方法一直具有挑战性。

观察结果

ENB强烈表达生长抑素受体(SSTRs),尤其是SSTR2,为成像和治疗提供了分子靶点。

经验教训

作者展示了一组用[68Ga] - DOTATATE PET/MRI和PET/CT成像的ENB病例系列,并讨论了[68Ga] - DOTATATE PET在ENB诊断、分期和治疗反应监测中的新兴作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe97/9241319/c4d0598ddf04/CASE2058f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe97/9241319/aa3f00c97da9/CASE2058f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe97/9241319/a0c6c2654ece/CASE2058f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe97/9241319/85ac99638187/CASE2058f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe97/9241319/c4d0598ddf04/CASE2058f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe97/9241319/aa3f00c97da9/CASE2058f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe97/9241319/a0c6c2654ece/CASE2058f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe97/9241319/85ac99638187/CASE2058f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe97/9241319/c4d0598ddf04/CASE2058f4.jpg

相似文献

1
[68Ga]-DOTATATE PET/CT and PET/MRI in the diagnosis and management of esthesioneuroblastoma: illustrative cases.[68Ga]-DOTATATE PET/CT与PET/MRI在嗅神经母细胞瘤诊断与治疗中的应用:病例展示
J Neurosurg Case Lessons. 2021 Jan 11;1(2):CASE2058. doi: 10.3171/CASE2058.
2
Prevalence of hitherto unknown brain meningioma detected on Ga-DOTATATE positron-emission tomography/computed tomography in patients with metastatic neuroendocrine tumor and exploring potential of Lu-DOTATATE peptide receptor radionuclide therapy as single-shot treatment approach targeting both tumors.在转移性神经内分泌肿瘤患者中,通过镓- DOTATATE正电子发射断层扫描/计算机断层扫描检测到迄今未知的脑脑膜瘤,并探索镥- DOTATATE肽受体放射性核素治疗作为针对两种肿瘤的单次治疗方法的潜力。
World J Nucl Med. 2019 Apr-Jun;18(2):160-170. doi: 10.4103/wjnm.WJNM_39_18.
3
Correlation and Comparison of Somatostatin Receptor Type 2 Immunohistochemical Scoring Systems with 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography Imaging in Gastroenteropancreatic Neuroendocrine Neoplasms.胃胰神经内分泌肿瘤中生长抑素受体 2 免疫组织化学评分系统与 68Ga-DOTATATE 正电子发射断层扫描/计算机断层成像的相关性和比较。
Neuroendocrinology. 2022;112(4):358-369. doi: 10.1159/000517530. Epub 2021 Jun 2.
4
Neuroradiological and Neuropathological Changes After 177Lu-Octreotate Peptide Receptor Radionuclide Therapy of Refractory Esthesioneuroblastoma.177Lu-奥曲肽肽受体放射性核素治疗难治性嗅神经母细胞瘤后的神经影像学和神经病理学变化。
Oper Neurosurg (Hagerstown). 2018 Dec 1;15(6):100-109. doi: 10.1093/ons/opy028.
5
Quantitative and qualitative intrapatient comparison of 68Ga-DOTATOC and 68Ga-DOTATATE: net uptake rate for accurate quantification.68Ga-DOTATOC与68Ga-DOTATATE的患者体内定量和定性比较:用于准确量化的净摄取率
J Nucl Med. 2014 Feb;55(2):204-10. doi: 10.2967/jnumed.113.126177. Epub 2013 Dec 30.
6
Performance of 177Lu-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics.基于¹⁷⁷Lu-DOTATATE的肽受体放射性核素治疗在转移性胃肠胰神经内分泌肿瘤中的应用:一项与原发肿瘤部位、肿瘤增殖指数及双示踪剂成像特征相关的多参数反应评估
Nucl Med Commun. 2016 Oct;37(10):1030-7. doi: 10.1097/MNM.0000000000000547.
7
The value of Gallium-DOTATATE PET/CT in sinonasal neuroendocrine tumor management: A case series.镓- DOTATATE PET/CT 在鼻窦神经内分泌肿瘤管理中的价值:病例系列。
Head Neck. 2021 Jun;43(6):E30-E40. doi: 10.1002/hed.26695. Epub 2021 Mar 31.
8
68Ga-DOTATATE and 18F-FDG PET/CT for the Management of Esthesioneuroblastoma of the Sphenoclival Region.68Ga-DOTATATE 和 18F-FDG PET/CT 用于蝶鞍斜坡区嗅神经母细胞瘤的治疗管理。
Clin Nucl Med. 2020 Aug;45(8):e363-e364. doi: 10.1097/RLU.0000000000003133.
9
Somatostatin receptor imaging with [Ga]Ga-DOTATATE positron emission tomography/computed tomography (PET/CT) in patients with nasopharyngeal carcinoma.[镓]镓- DOTATATE正电子发射断层扫描/计算机断层扫描(PET/CT)对鼻咽癌患者进行生长抑素受体显像
Eur J Nucl Med Mol Imaging. 2022 Mar;49(4):1360-1373. doi: 10.1007/s00259-021-05587-7. Epub 2021 Oct 19.
10
DOTATATE PET Imaging in Olfactory Neuroblastoma and Association with SSTR Expression.奥曲肽受体显像剂DOTATATE在嗅神经母细胞瘤中的应用及其与生长抑素受体表达的关系
J Neurol Surg B Skull Base. 2023 Jun 12;85(5):439-444. doi: 10.1055/a-2096-1802. eCollection 2024 Oct.

引用本文的文献

1
Characterization of Somatostatin Receptor 2 Gene Expression and Immune Landscape in Sinonasal Malignancies.鼻窦恶性肿瘤中生长抑素受体2基因表达及免疫格局的特征分析
Cancers (Basel). 2024 Nov 24;16(23):3931. doi: 10.3390/cancers16233931.
2
Personalized Approach to Olfactory Neuroblastoma Care.嗅神经母细胞瘤个体化治疗方案
J Pers Med. 2024 Apr 16;14(4):423. doi: 10.3390/jpm14040423.
3
Olfactory neuroblastoma: diagnosis, management, and current treatment options.嗅神经母细胞瘤:诊断、管理及当前的治疗选择

本文引用的文献

1
Adrenocorticotropic Hormone-Secreting Esthesioneuroblastoma with Ectopic Cushing's Syndrome.促肾上腺皮质激素分泌性鼻腔鼻窦神经母细胞瘤伴异位库欣综合征。
Yonsei Med J. 2020 Mar;61(3):257-261. doi: 10.3349/ymj.2020.61.3.257.
2
Efficacy of Peptide Receptor Radionuclide Therapy for Esthesioneuroblastoma.多肽受体放射性核素疗法治疗鼻腔神经外胚层瘤的疗效。
J Nucl Med. 2020 Sep;61(9):1326-1330. doi: 10.2967/jnumed.119.237990. Epub 2020 Jan 31.
3
Molecular imaging and therapy of somatostatin receptor positive tumors.生长抑素受体阳性肿瘤的分子影像学与治疗。
Front Oncol. 2023 Oct 16;13:1242453. doi: 10.3389/fonc.2023.1242453. eCollection 2023.
4
PET/CT Imaging in Treatment Planning and Surveillance of Sinonasal Neoplasms.PET/CT成像在鼻窦肿瘤治疗计划与监测中的应用
Cancers (Basel). 2023 Jul 25;15(15):3759. doi: 10.3390/cancers15153759.
5
Somatostatin Receptor-PET/CT/MRI of Head and Neck Neuroendocrine Tumors.头颈部神经内分泌肿瘤的生长抑素受体 PET/CT/MRI
AJNR Am J Neuroradiol. 2023 Aug;44(8):959-966. doi: 10.3174/ajnr.A7934. Epub 2023 Jul 13.
6
[68 Ga]-DOTATATE PET/MR-based evaluation of physiologic somatostatin receptor 2 expression in the adult pituitary gland as a function of age and sex in a prospective cohort.[68Ga]-DOTATATE PET/MR 基于前瞻性队列研究评估成人垂体中生长抑素受体 2 的生理表达与年龄和性别之间的关系。
Pituitary. 2023 Aug;26(4):419-428. doi: 10.1007/s11102-023-01329-0. Epub 2023 Jun 7.
Clin Imaging. 2019 Jul-Aug;56:146-154. doi: 10.1016/j.clinimag.2019.04.006. Epub 2019 Apr 15.
4
Comparing Kadish, TNM, and the modified Dulguerov staging systems for esthesioneuroblastoma.比较Kadish、TNM和改良的Dulguerov分期系统用于嗅神经母细胞瘤的情况。
J Surg Oncol. 2019 Jan;119(1):130-142. doi: 10.1002/jso.25293. Epub 2018 Nov 22.
5
Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With Lu-Dotatate in the Phase III NETTER-1 Trial.在 III 期 NETTER-1 试验中,接受 Lu-Dotatate 治疗的进展性中肠神经内分泌肿瘤患者的生活质量与健康相关。
J Clin Oncol. 2018 Sep 1;36(25):2578-2584. doi: 10.1200/JCO.2018.78.5865. Epub 2018 Jun 7.
6
Neuroradiological and Neuropathological Changes After 177Lu-Octreotate Peptide Receptor Radionuclide Therapy of Refractory Esthesioneuroblastoma.177Lu-奥曲肽肽受体放射性核素治疗难治性嗅神经母细胞瘤后的神经影像学和神经病理学变化。
Oper Neurosurg (Hagerstown). 2018 Dec 1;15(6):100-109. doi: 10.1093/ons/opy028.
7
Sinonasal Neuroendocrine Neoplasms: Current Challenges and Advances in Diagnosis and Treatment, with a Focus on Olfactory Neuroblastoma.鼻窦神经内分泌肿瘤:诊断与治疗的当前挑战与进展,重点关注嗅神经母细胞瘤
Head Neck Pathol. 2018 Mar;12(1):22-30. doi: 10.1007/s12105-018-0887-5. Epub 2018 Feb 9.
8
Olfactory Neuroblastoma.嗅神经母细胞瘤。
Curr Oncol Rep. 2018 Feb 7;20(1):7. doi: 10.1007/s11912-018-0661-6.
9
Lutetium 177-DOTA-TATE therapy for esthesioneuroblastoma: A case report.镥-177-DOTA-奥曲肽治疗嗅神经母细胞瘤:一例报告。
Exp Ther Med. 2016 Nov;12(5):3078-3082. doi: 10.3892/etm.2016.3732. Epub 2016 Sep 20.
10
Imaging Characteristics of Olfactory Neuroblastoma (Esthesioneuroblastoma).嗅神经母细胞瘤(嗅神经上皮瘤)的影像学特征
J Neurol Surg B Skull Base. 2016 Feb;77(1):1-5. doi: 10.1055/s-0035-1564053. Epub 2015 Sep 14.